09:11 AM EDT, 10/08/2025 (MT Newswires) -- Health care stocks were mixed pre-bell Wednesday, with the Health Care Select Sector SPDR Fund (XLV) slightly lower and the iShares Biotechnology ETF (IBB) up 0.3% and 0.2%, respectively.

Zenas BioPharma ( ZBIO ) has been granted a license for the global development and commercialization rights to orelabrutinib for multiple sclerosis and all therapeutic areas other than oncology from InnoCare Pharma, the companies said. Zenas BioPharma ( ZBIO ) shares were up more than 13% premarket.